Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tideglusib in adolescents with ASD
NCT02586935Phase 2Completed
- Sponsor
- Holland Bloorview Kids Rehabilitation Hospital
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Tideglusib with Placebo (2 arms). Primary endpoint: Measures of social engagement/withdrawal at 12 weeks. Started Feb 2016; status: completed.
02
Drugs
tideglusib
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02586935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586935.